Sorry, you need to enable JavaScript to visit this website.

DEXTROSE (Dextrose ADD-Vantage™ Diluent) Principal Display Panel

IM-3522

Bag NDC 0409-7100-68

IM-3523

Bag NDC 0409-7100-69

PRINCIPAL DISPLAY PANEL - 250 mL Bag Label

LOT
EXP.

PULL INNER PLUG/STOPPER
AND MIX DRUG BEFORE USE

ADD-Vantage™ Unit
NDC 0409-7100-04

5% DEXTROSE
Injection, USP
250 mL

EACH 100 mL CONTAINS
DEXTROSE, HYDROUS 5 g.
253 mOsmol/LITER (calc).
pH 4.3 (3.2 TO 6.5)
DEXTROSE SOLUTIONS
WITHOUT SALTS SHOULD
NOT BE USED IN BLOOD
TRANSFUSIONS BECAUSE
OF POSSIBLE ROULEAU
FORMATION. FOR USE ONLY
WITH ADD-Vantage™ SYSTEM
COMPONENTS. SINGLE-
DOSE CONTAINER. FOR
INTRAVENOUS USE. USUAL
DOSAGE
: SEE INSERT. STERILE,
NONPYROGENIC. USE ONLY
IF SOLUTION IS CLEAR AND
CONTAINER IS UNDAMAGED.
MUST NOT BE USED IN SERIES
CONNECTIONS.

Rx ONLY

3
v
CONTAINS DEHP

Hospira

IM-3524
HOSPIRA, INC., LAKE FOREST, IL 60045 USA

PRINCIPAL DISPLAY PANEL - 250 mL Bag Label

PRINCIPAL DISPLAY PANEL - Pouch Label - WR-0425

One/ADD-Vantage™ Unit
TO OPEN–PEEL AT CORNER

For use only with ADD-Vantage™ system components.

The overwrap is a moisture barrier. Do not remove unit from overwrap
until ready for use. Use unit promptly when pouch is opened. Store at
20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Protect
from freezing. See insert. After removing the overwrap, check for minute
leaks by squeezing container firmly. If leaks are found, discard unit as
sterility may be impaired.

Rx only

WR-0425

HOSPIRA, INC., LAKE FOREST, IL 60045 USA

Hospira

PRINCIPAL DISPLAY PANEL - Pouch Label - WR-0425

What's New

No Current Announcements.

Search

Please enter your search term(s) for DEXTROSE